Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From Investor Relations

In response to an e-mail I sent.

The ITC trial has concluded. Counsel for the MMP put forth a tremendous effort and we believe they did a fantastic job. We, like you, anxiously await the Court's ruling which is expected to be delieverd on Sept. 6th. Our successes will be promoted as they are achieved.

Share
New Message
Please login to post a reply